Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson's Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning.
Overview
- Department of Neurology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China, sxmu.edu.cn
- Department of Neurology, Taiyuan City Central Hospital, Peking University First Hospital Taiyuan Branch, The Ninth Clinical Medical College of Shanxi Medical University, Taiyuan, Shanxi, China
- Changzhi Medical College, Changzhi, Shanxi, China, czmc.com
- School of Software, North University of China, Taiyuan, Shanxi, China, nuc.edu.cn
Abstract
Background: Parkinson’s disease (PD) is a prevalent neurodegenerative disease, whereas nonalcoholic fatty liver disease (NAFLD) is a common metabolic liver disorder. Growing evidence suggests that NAFLD may affect the central nervous system through the liver–brain axis, potentially contributing to PD, although the underlying molecular mechanisms remain unclear.
Methods: To identify differentially expressed genes (DEGs), transcriptomic data for NAFLD and PD were sourced from the GEO database. Key common candidate genes were screened using protein–protein interaction (PPI) networks, machine learning approaches (LASSO, neural networks, and random forest), and functional enrichment analyses, including GO, KEGG, GSEA, and GSVA. Immune infiltration, TF‐miRNA regulatory networks, and single‐cell RNA sequencing analyses were applied to investigate gene function, immune regulation, and cellular distribution. Candidate drugs were predicted using bioinformatic approaches and validated through molecular docking.
Results: CASP1, CCNA2, and INHBE were identified as three core common candidate genes that may be associated with NAFLD and PD. Involvement of these genes includes inflammatory responses, regulation of the cell cycle, metabolic pathways, and immune microenvironment remodeling. The analysis of the TF‐miRNA network suggested possible regulation by transcription factors CEBPB, BRD4, FOS, and miRNAs such as hsa‐miR‐29b‐1‐5p and hsa‐miR‐128‐3p. Drug prediction and molecular docking identified ethinyl estradiol, mesalamine, and seliciclib as candidate therapeutics, showing strong binding affinity to the core targets.
Conclusion: This study offers a comprehensive elucidation of the molecular ties between NAFLD and PD. The identified core genes and candidate drugs offer theoretical support for potential candidate biomarkers and therapeutic targets in comorbid NAFLD and PD.
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “2.1. The Data Source”
Data Availability Statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Issue: n/a → 1
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 4 authors, 7 keywords, 1 funder, 57 references.
Cite
This paper
Chen, X., Wu, Y., Zhang, Y., & Hou, Y. (2026). Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson's Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning. Parkinson's disease, 2026(1), 8731032. https://
BibTeX
@article{chen2026identif
author = {Chen, Xuan and Wu, Yulin and Zhang, Yonglai and Hou, Yuli},
title = {{Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson's Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning}},
journal = {Parkinson's disease},
year = {2026},
month = may,
volume = {2026},
number = {1},
pages = {8731032},
publisher = {Wiley},
issn = {2090-8083},
doi = {10.1155/
url = {https://
pmid = {42205493},
pmcid = {PMC13202728}
}
RIS
TY - JOUR
AU - Chen, Xuan
AU - Wu, Yulin
AU - Zhang, Yonglai
AU - Hou, Yuli
TI - Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson's Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning
T2 - Parkinson's disease
J2 - Parkinsons Dis
PY - 2026
DA - 2026/
VL - 2026
IS - 1
SP - 8731032
SN - 2090-8083
PB - Wiley
DO - 10.1155/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1155/
"type": "article-journal",
"title": "Identification of Gene Signatures and Molecular Mechanisms for Diagnosing Parkinson's Disease and Nonalcoholic Fatty Liver Disease Using Machine Learning",
"container-title": "Parkinson's disease",
"author": [
{
"family": "Chen",
"given": "Xuan"
},
{
"family": "Wu",
"given": "Yulin"
},
{
"family": "Zhang",
"given": "Yonglai"
},
{
"family": "Hou",
"given": "Yuli"
}
],
"container-title-short":
"volume": "2026",
"issue": "1",
"page": "8731032",
"DOI": "10.1155/
"PMID": "42205493",
"PMCID": "PMC13202728",
"ISSN": "2090-8083",
"publisher": "Wiley",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
26
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1002/advs.77175
- TAB2 Causes Neuronal Damage by Aggravating Microglia-Mediated Neuroinflammation in Parkinson's Disease.Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)In common: Parkinson's, cellular / molecular, 2 references
- [2] doi:10.1186/s12974-023-02776-z
- PARK7/
DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target. Journal: Journal of neuroinflammationIn common: Parkinson's, cellular / molecular, 2 references - [3] doi:10.1016/j.isci.2024.110766
- β-chitosan attenuates hepatic macrophage-driven inflammation and reverses aging-related cognitive impairment.Journal: iScienceIn common: cellular / molecular, 2 references
- [4] doi:10.1016/j.ebiom.2023.104679
- Elevated C-reactive protein mediates the liver-brain axis: a preliminary study.Journal: EBioMedicineIn common: cellular / molecular, 2 references
- [5] doi:10.1038/s41598-022-05228-5
- MAFLD progression contributes to altered thalamus metabolism and brain structure.Journal: Scientific reportsIn common: 2 references
- [6] doi:10.3389/fnagi.2025.1676721 [code]
- Mediating role of muscle quality in the liver-brain axis: integrated analysis of CT markers of body composition, brain aging, and biomarkers.Journal: Frontiers in aging neuroscienceIn common: 2 references
- [7] doi:10.3390/metabo16080541
- Spatial Metabolomics and Single-Cell Virtual Knockout Screening Reveal Solanesol Improves Parkinson's Disease-like Pathology Based on Lipid Inflammation Mechanism.Journal: MetabolitesIn common: Parkinson's, genetics / omics, cellular / molecular, 1 reference
- [8] doi:10.1093/brain/awac193 [code]
- A Mendelian randomization study investigating the causal role of inflammation on Parkinson's disease.Journal: Brain : a journal of neurologyIn common: Parkinson's, genetics / omics, cellular / molecular, 1 reference
- [9] doi:10.3389/fnins.2021.733501 [code]
- Transcriptomic Signatures Associated With Regional Cortical Thickness Changes in Parkinson's Disease.Journal: Frontiers in neuroscienceIn common: Parkinson's, genetics / omics, cellular / molecular, 1 reference
- [10] doi:10.1186/s13041-025-01262-2
- Dysregulated circRNA-miRNA-mRNA networks reveal stage-specific mRNA expression changes in Parkinson's disease.Journal: Molecular brainIn common: Parkinson's, genetics / omics, cellular / molecular, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
